百欧海文制药 BHVN
$14.48 +$0.58 (+4.17%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.58 +0.69%
开盘$14.23
昨收$13.90
当日区间$13.76 – $14.50
成交量2.92M
市值$2.19B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$0.00
营业利润-$126.42M+25.4% YoY
净利润-$129.28M+25.5% YoY
摊薄每股收益-$0.86+47.6% YoY
自由现金流-$107.03M+26.6% YoY
经营现金流-$106.85M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
资产收益率-161.3%
流动比率3.05
负债/资产比率137.3%
现金及投资$161.13M
总负债$295.70M
净现金（净负债）-$134.58M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $126.42M | $124.90M | $130.43M | $745.38M | $142.73M |
| 销售及管理费用 | $24.57M | $24.09M | $26.60M | $110.31M | $20.79M |
| -管理费用 | $24.57M | $24.09M | $26.60M | $110.31M | $20.79M |
| 研发费用 | $101.85M | $100.81M | $103.83M | $635.07M | $121.95M |
| 营业利润 | -$126.42M | -$124.90M | -$130.43M | -$745.38M | -$142.73M |
| 其他收入（支出） | -$2.92M | -$12.02M | $168,000.00 | $8.00M | -$2.47M |
| 其他非经营性收入（支出） | -$2.92M | -$12.02M | $168,000.00 | $8.00M | -$2.47M |
| 税前利润 | -$129.34M | -$136.92M | -$130.26M | -$737.38M | -$145.20M |
| 税费 | -$64,000.00 | $391,000.00 | $272,000.00 | $1.44M | $351,000.00 |
| 净利润 | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| 持续经营利润 | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| 归属母公司净利润 | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| 归属普通股股东净利润 | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| 基本每股收益 | -$0.86 | -$0.91 | -$0.88 | -$6.86 | -$1.21 |
| 摊薄每股收益 | -$0.86 | -$0.91 | -$0.88 | -$6.86 | -$1.21 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $263.68M | $370.74M | $466.41M | $451.45M | $451.45M |
| 流动资产合计 | $191.51M | $296.56M | $385.65M | $368.33M | $368.33M |
| 现金及现金等价物与短期投资 | $161.13M | $267.87M | $347.82M | $319.14M | $319.14M |
| -现金及现金等价物 | $95.75M | $238.03M | $273.07M | $229.96M | $229.96M |
| -短期投资 | $65.37M | $29.83M | $74.74M | $89.18M | $89.18M |
| 预付资产 | $27.57M | $27.04M | $34.67M | $47.02M | $47.02M |
| 其他流动资产 | $2.82M | $1.65M | $3.17M | $2.17M | $2.17M |
| 非流动资产合计 | $72.16M | $73.89M | $80.76M | $83.12M | $83.12M |
| 固定资产净值 | $50.23M | $51.60M | $58.66M | $61.02M | $61.02M |
| -固定资产原值 | $68.26M | $69.05M | $75.49M | $77.15M | $77.15M |
| -累计折旧 | -$18.02M | -$17.46M | -$16.83M | -$16.13M | -$16.13M |
| 商誉及其他无形资产 | $19.79M | $19.79M | $19.79M | $19.79M | $19.79M |
| -商誉 | $1.39M | $1.39M | $1.39M | $1.39M | $1.39M |
| -其他无形资产 | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M |
| 其他非流动资产 | $2.14M | $2.50M | $2.31M | $2.31M | $2.31M |
| 负债合计 | $361.92M | $358.52M | $336.91M | $399.38M | $399.38M |
| 流动负债合计 | $62.77M | $62.66M | $52.08M | $115.93M | $115.93M |
| 应付款 | $13.53M | $12.11M | $10.42M | $11.64M | $11.64M |
| -应付账款 | $13.53M | $12.11M | $10.42M | $11.64M | $11.64M |
| 一年内应计费用 | $32.39M | $37.65M | $31.33M | $39.04M | $39.04M |
| 短期债务及融资租赁负债 | $4.74M | $4.67M | $5.90M | $5.76M | $5.76M |
| -一年内到期融资租赁负债 | $4.74M | $4.67M | $5.90M | $5.76M | $5.76M |
| 非流动负债合计 | $299.16M | $295.86M | $284.83M | $283.44M | $283.44M |
| 长期债务及融资租赁负债 | $295.70M | $292.37M | $280.28M | $278.86M | $278.86M |
| -长期债务 | $264.29M | $259.48M | $241.91M | $238.90M | $238.90M |
| -长期融资租赁负债 | $31.41M | $32.89M | $38.36M | $39.96M | $39.96M |
| 其他非流动负债 | $3.46M | $3.49M | $4.56M | $4.58M | $4.58M |
| 股东权益合计 | -$98.25M | $12.22M | $129.50M | $52.07M | $52.07M |
| 股东权益 | -$98.25M | $12.22M | $129.50M | $52.07M | $52.07M |
| 股本 | $2.14B | $2.14B | $2.13B | $1.93B | $1.93B |
| -普通股 | $2.14B | $2.14B | $2.13B | $1.93B | $1.93B |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $238.84M | $220.37M | $203.36M | $193.98M | $193.98M |
| 留存收益 | -$2.48B | -$2.35B | -$2.22B | -$2.08B | -$2.08B |
| 不影响留存收益的损益 | $5.35M | $5.38M | $8.30M | $8.35M | $8.35M |
| 其他流动负债 | – | – | – | $42.71M | $42.71M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$106.85M | -$85.10M | -$149.92M | -$609.44M | -$130.66M |
| 持续经营经营活动现金流净额 | -$106.85M | -$85.10M | -$149.92M | -$609.44M | -$130.66M |
| 持续经营净利润 | -$129.28M | -$137.31M | -$130.53M | -$738.82M | -$145.56M |
| 折旧、折耗与摊销 | $2.22M | $2.26M | $2.37M | $9.92M | $2.57M |
| 其他非现金项目 | -$18.06M | $17.13M | $21,000.00 | $5.02M | $5.58M |
| 营运资金变动 | -$2.82M | $16.67M | -$53.07M | $1.36M | -$9.83M |
| -预付资产变动 | -$1.41M | $7.52M | $12.56M | $3.53M | $8.82M |
| -应付账款及应计费用变动 | -$1.41M | $9.15M | -$65.64M | -$2.17M | -$18.64M |
| 投资活动现金流净额 | -$35.33M | $44.82M | $15.21M | $300.56M | -$13.74M |
| 持续经营投资活动现金流净额 | -$35.33M | $44.82M | $15.21M | $300.56M | -$13.74M |
| 固定资产购置及出售净额 | -$180,000.00 | -$454,000.00 | $0.00 | -$715,000.00 | -$8,000.00 |
| 投资购置及出售净额 | -$35.15M | $45.28M | $15.21M | $303.13M | -$13.73M |
| 筹资活动现金流 | $211,000.00 | $3.80M | $179.02M | $439.12M | $188.80M |
| 持续经营筹资活动现金流净额 | $211,000.00 | $3.80M | $179.02M | $439.12M | $188.80M |
| 债务发行及偿还净额 | $0.00 | – | – | $250.00M | $0.00 |
| 普通股发行净额 | $0.00 | $0.00 | $178.88M | $189.18M | $189.18M |
| 股票期权行使所得 | $211,000.00 | $3.80M | $132,000.00 | $1.83M | $265,000.00 |
| 期末现金余额 | $98.66M | $240.63M | $277.11M | $232.78M | $232.78M |
| 现金净变动 | -$141.97M | -$36.48M | $44.31M | $130.24M | $44.40M |
| 期初现金余额 | $240.63M | $277.11M | $232.78M | $102.54M | $188.38M |
| 汇率变动影响 | $0.00 | $3,000.00 | $16,000.00 | -$3,000.00 | $0.00 |
| 自由现金流 | -$107.03M | -$85.55M | -$149.92M | -$610.15M | -$130.67M |
| 持续经营损益 | – | – | – | $9.43M | $20.70M |
| 无形资产购置及出售净额 | – | – | – | $0.00 | – |
| 其他投资变动净额 | – | – | – | -$1.85M | $0.00 |
| 其他筹资费用净额 | – | – | – | -$1.89M | -$644,000.00 |
暂无评论——快来第一个聊聊 BHVN。
登录后参与讨论。